PSI Webinar: How can PSI, “a community dedicated to leading and promoting the use of statistics within the healthcare industries for the benefit of patients”, help you be more successful in your career?
Date: Thursday 23rd April 2020 Time: 10:00 - 11:00 Speakers: Chrissie Fletcher (GSK) and Nigel Howitt (Covance) Benefit of attending: 'Exposure to industry leaders and their views on the advantages of being part of the PSI community'
Have you ever wondered what it takes to be successful as a statistician or data scientist in the healthcare/pharma industry and what can give you the extra edge to develop your career? Come and listen to these industry leaders views on how to be successful and the advantages of being part of the PSI community.
Please click here to register for this webinar.
This webinar is free for both Members and Non Members of PSI.
Speaker
Bio
Chrissie Fletcher
GSK
Chrissie has recently joined GSK as Vice President, Development Biostatistics. Prior to GSK, Chrissie worked at Amgen for 22+ years where she was the Biostatistics Therapeutic Area Head for Cardiovascular, Metabolic, Neuroscience, Nephrology and Inflammation. Chrissie has worked in the Pharmaceutical Industry for 29 years and she has experience of developing and commercialising new medicines in a variety of therapeutic areas across all phases of clinical development. Chrissie is actively engaged in Statistical societies (e.g. PSI, EFSPI), Pharmaceutical trade associations (e.g. EFPIA) and initiatives relating to the Pharmaceutical Industry (e.g. ICH, IMI). In 2019 Chrissie was awarded PSI Honorary Member for her outstanding services to PSI, and she was an awardee of the Women in Data 2019 ‘Twenty Women in Data & Technology’ where she was recognised as an outstanding Women Leader.
Nigel Howitt Covance
Nigel is the Global Head and Executive Director of Biostatistics at Covance, covering Phases I to IV. He leads a department of >100 Biostatisticians from North America, EU, India and China. Nigel has 27 years of industry experience; 26 years at CROs (parexel, PRA Health Sciences and Covance). He was the Global Head of Biostatistics at PRA between 2009 to 2016 prior to joining Covance.
Nigel has been an active member of professional organizations for many years. He has served twice on the PSI Board and on the Scientific Committee. He was the PSI Chair between July 2017 and July 2019, and is currently the Vice-Chair and Secretary. Nigel also served on the EFSPI Council and was the EFSPI President between 2007 and 2010.
Nigel has a Postgraduate Diploma in Mathematical Statistics from Cambridge University (UK) and a BSc (hons) in Mathematics and Statistics from Bradford University (UK).
Outside of work Nigel loves rugby, football, music and visiting the West End.
Scientific Meetings
PSI Webinar: How can PSI, “a community dedicated to leading and promoting the use of statistics within the healthcare industries for the benefit of patients”, help you be more successful in your career?
Date: Thursday 23rd April 2020 Time: 10:00 - 11:00 Speakers: Chrissie Fletcher (GSK) and Nigel Howitt (Covance) Benefit of attending: 'Exposure to industry leaders and their views on the advantages of being part of the PSI community'
Have you ever wondered what it takes to be successful as a statistician or data scientist in the healthcare/pharma industry and what can give you the extra edge to develop your career? Come and listen to these industry leaders views on how to be successful and the advantages of being part of the PSI community.
Please click here to register for this webinar.
This webinar is free for both Members and Non Members of PSI.
Speaker
Bio
Chrissie Fletcher
GSK
Chrissie has recently joined GSK as Vice President, Development Biostatistics. Prior to GSK, Chrissie worked at Amgen for 22+ years where she was the Biostatistics Therapeutic Area Head for Cardiovascular, Metabolic, Neuroscience, Nephrology and Inflammation. Chrissie has worked in the Pharmaceutical Industry for 29 years and she has experience of developing and commercialising new medicines in a variety of therapeutic areas across all phases of clinical development. Chrissie is actively engaged in Statistical societies (e.g. PSI, EFSPI), Pharmaceutical trade associations (e.g. EFPIA) and initiatives relating to the Pharmaceutical Industry (e.g. ICH, IMI). In 2019 Chrissie was awarded PSI Honorary Member for her outstanding services to PSI, and she was an awardee of the Women in Data 2019 ‘Twenty Women in Data & Technology’ where she was recognised as an outstanding Women Leader.
Nigel Howitt Covance
Nigel is the Global Head and Executive Director of Biostatistics at Covance, covering Phases I to IV. He leads a department of >100 Biostatisticians from North America, EU, India and China. Nigel has 27 years of industry experience; 26 years at CROs (parexel, PRA Health Sciences and Covance). He was the Global Head of Biostatistics at PRA between 2009 to 2016 prior to joining Covance.
Nigel has been an active member of professional organizations for many years. He has served twice on the PSI Board and on the Scientific Committee. He was the PSI Chair between July 2017 and July 2019, and is currently the Vice-Chair and Secretary. Nigel also served on the EFSPI Council and was the EFSPI President between 2007 and 2010.
Nigel has a Postgraduate Diploma in Mathematical Statistics from Cambridge University (UK) and a BSc (hons) in Mathematics and Statistics from Bradford University (UK).
Outside of work Nigel loves rugby, football, music and visiting the West End.
Training Courses
PSI Webinar: How can PSI, “a community dedicated to leading and promoting the use of statistics within the healthcare industries for the benefit of patients”, help you be more successful in your career?
Date: Thursday 23rd April 2020 Time: 10:00 - 11:00 Speakers: Chrissie Fletcher (GSK) and Nigel Howitt (Covance) Benefit of attending: 'Exposure to industry leaders and their views on the advantages of being part of the PSI community'
Have you ever wondered what it takes to be successful as a statistician or data scientist in the healthcare/pharma industry and what can give you the extra edge to develop your career? Come and listen to these industry leaders views on how to be successful and the advantages of being part of the PSI community.
Please click here to register for this webinar.
This webinar is free for both Members and Non Members of PSI.
Speaker
Bio
Chrissie Fletcher
GSK
Chrissie has recently joined GSK as Vice President, Development Biostatistics. Prior to GSK, Chrissie worked at Amgen for 22+ years where she was the Biostatistics Therapeutic Area Head for Cardiovascular, Metabolic, Neuroscience, Nephrology and Inflammation. Chrissie has worked in the Pharmaceutical Industry for 29 years and she has experience of developing and commercialising new medicines in a variety of therapeutic areas across all phases of clinical development. Chrissie is actively engaged in Statistical societies (e.g. PSI, EFSPI), Pharmaceutical trade associations (e.g. EFPIA) and initiatives relating to the Pharmaceutical Industry (e.g. ICH, IMI). In 2019 Chrissie was awarded PSI Honorary Member for her outstanding services to PSI, and she was an awardee of the Women in Data 2019 ‘Twenty Women in Data & Technology’ where she was recognised as an outstanding Women Leader.
Nigel Howitt Covance
Nigel is the Global Head and Executive Director of Biostatistics at Covance, covering Phases I to IV. He leads a department of >100 Biostatisticians from North America, EU, India and China. Nigel has 27 years of industry experience; 26 years at CROs (parexel, PRA Health Sciences and Covance). He was the Global Head of Biostatistics at PRA between 2009 to 2016 prior to joining Covance.
Nigel has been an active member of professional organizations for many years. He has served twice on the PSI Board and on the Scientific Committee. He was the PSI Chair between July 2017 and July 2019, and is currently the Vice-Chair and Secretary. Nigel also served on the EFSPI Council and was the EFSPI President between 2007 and 2010.
Nigel has a Postgraduate Diploma in Mathematical Statistics from Cambridge University (UK) and a BSc (hons) in Mathematics and Statistics from Bradford University (UK).
Outside of work Nigel loves rugby, football, music and visiting the West End.
Journal Club
PSI Webinar: How can PSI, “a community dedicated to leading and promoting the use of statistics within the healthcare industries for the benefit of patients”, help you be more successful in your career?
Date: Thursday 23rd April 2020 Time: 10:00 - 11:00 Speakers: Chrissie Fletcher (GSK) and Nigel Howitt (Covance) Benefit of attending: 'Exposure to industry leaders and their views on the advantages of being part of the PSI community'
Have you ever wondered what it takes to be successful as a statistician or data scientist in the healthcare/pharma industry and what can give you the extra edge to develop your career? Come and listen to these industry leaders views on how to be successful and the advantages of being part of the PSI community.
Please click here to register for this webinar.
This webinar is free for both Members and Non Members of PSI.
Speaker
Bio
Chrissie Fletcher
GSK
Chrissie has recently joined GSK as Vice President, Development Biostatistics. Prior to GSK, Chrissie worked at Amgen for 22+ years where she was the Biostatistics Therapeutic Area Head for Cardiovascular, Metabolic, Neuroscience, Nephrology and Inflammation. Chrissie has worked in the Pharmaceutical Industry for 29 years and she has experience of developing and commercialising new medicines in a variety of therapeutic areas across all phases of clinical development. Chrissie is actively engaged in Statistical societies (e.g. PSI, EFSPI), Pharmaceutical trade associations (e.g. EFPIA) and initiatives relating to the Pharmaceutical Industry (e.g. ICH, IMI). In 2019 Chrissie was awarded PSI Honorary Member for her outstanding services to PSI, and she was an awardee of the Women in Data 2019 ‘Twenty Women in Data & Technology’ where she was recognised as an outstanding Women Leader.
Nigel Howitt Covance
Nigel is the Global Head and Executive Director of Biostatistics at Covance, covering Phases I to IV. He leads a department of >100 Biostatisticians from North America, EU, India and China. Nigel has 27 years of industry experience; 26 years at CROs (parexel, PRA Health Sciences and Covance). He was the Global Head of Biostatistics at PRA between 2009 to 2016 prior to joining Covance.
Nigel has been an active member of professional organizations for many years. He has served twice on the PSI Board and on the Scientific Committee. He was the PSI Chair between July 2017 and July 2019, and is currently the Vice-Chair and Secretary. Nigel also served on the EFSPI Council and was the EFSPI President between 2007 and 2010.
Nigel has a Postgraduate Diploma in Mathematical Statistics from Cambridge University (UK) and a BSc (hons) in Mathematics and Statistics from Bradford University (UK).
Outside of work Nigel loves rugby, football, music and visiting the West End.
Webinars
PSI Webinar: How can PSI, “a community dedicated to leading and promoting the use of statistics within the healthcare industries for the benefit of patients”, help you be more successful in your career?
Date: Thursday 23rd April 2020 Time: 10:00 - 11:00 Speakers: Chrissie Fletcher (GSK) and Nigel Howitt (Covance) Benefit of attending: 'Exposure to industry leaders and their views on the advantages of being part of the PSI community'
Have you ever wondered what it takes to be successful as a statistician or data scientist in the healthcare/pharma industry and what can give you the extra edge to develop your career? Come and listen to these industry leaders views on how to be successful and the advantages of being part of the PSI community.
Please click here to register for this webinar.
This webinar is free for both Members and Non Members of PSI.
Speaker
Bio
Chrissie Fletcher
GSK
Chrissie has recently joined GSK as Vice President, Development Biostatistics. Prior to GSK, Chrissie worked at Amgen for 22+ years where she was the Biostatistics Therapeutic Area Head for Cardiovascular, Metabolic, Neuroscience, Nephrology and Inflammation. Chrissie has worked in the Pharmaceutical Industry for 29 years and she has experience of developing and commercialising new medicines in a variety of therapeutic areas across all phases of clinical development. Chrissie is actively engaged in Statistical societies (e.g. PSI, EFSPI), Pharmaceutical trade associations (e.g. EFPIA) and initiatives relating to the Pharmaceutical Industry (e.g. ICH, IMI). In 2019 Chrissie was awarded PSI Honorary Member for her outstanding services to PSI, and she was an awardee of the Women in Data 2019 ‘Twenty Women in Data & Technology’ where she was recognised as an outstanding Women Leader.
Nigel Howitt Covance
Nigel is the Global Head and Executive Director of Biostatistics at Covance, covering Phases I to IV. He leads a department of >100 Biostatisticians from North America, EU, India and China. Nigel has 27 years of industry experience; 26 years at CROs (parexel, PRA Health Sciences and Covance). He was the Global Head of Biostatistics at PRA between 2009 to 2016 prior to joining Covance.
Nigel has been an active member of professional organizations for many years. He has served twice on the PSI Board and on the Scientific Committee. He was the PSI Chair between July 2017 and July 2019, and is currently the Vice-Chair and Secretary. Nigel also served on the EFSPI Council and was the EFSPI President between 2007 and 2010.
Nigel has a Postgraduate Diploma in Mathematical Statistics from Cambridge University (UK) and a BSc (hons) in Mathematics and Statistics from Bradford University (UK).
Outside of work Nigel loves rugby, football, music and visiting the West End.
Careers Meetings
PSI Webinar: How can PSI, “a community dedicated to leading and promoting the use of statistics within the healthcare industries for the benefit of patients”, help you be more successful in your career?
Date: Thursday 23rd April 2020 Time: 10:00 - 11:00 Speakers: Chrissie Fletcher (GSK) and Nigel Howitt (Covance) Benefit of attending: 'Exposure to industry leaders and their views on the advantages of being part of the PSI community'
Have you ever wondered what it takes to be successful as a statistician or data scientist in the healthcare/pharma industry and what can give you the extra edge to develop your career? Come and listen to these industry leaders views on how to be successful and the advantages of being part of the PSI community.
Please click here to register for this webinar.
This webinar is free for both Members and Non Members of PSI.
Speaker
Bio
Chrissie Fletcher
GSK
Chrissie has recently joined GSK as Vice President, Development Biostatistics. Prior to GSK, Chrissie worked at Amgen for 22+ years where she was the Biostatistics Therapeutic Area Head for Cardiovascular, Metabolic, Neuroscience, Nephrology and Inflammation. Chrissie has worked in the Pharmaceutical Industry for 29 years and she has experience of developing and commercialising new medicines in a variety of therapeutic areas across all phases of clinical development. Chrissie is actively engaged in Statistical societies (e.g. PSI, EFSPI), Pharmaceutical trade associations (e.g. EFPIA) and initiatives relating to the Pharmaceutical Industry (e.g. ICH, IMI). In 2019 Chrissie was awarded PSI Honorary Member for her outstanding services to PSI, and she was an awardee of the Women in Data 2019 ‘Twenty Women in Data & Technology’ where she was recognised as an outstanding Women Leader.
Nigel Howitt Covance
Nigel is the Global Head and Executive Director of Biostatistics at Covance, covering Phases I to IV. He leads a department of >100 Biostatisticians from North America, EU, India and China. Nigel has 27 years of industry experience; 26 years at CROs (parexel, PRA Health Sciences and Covance). He was the Global Head of Biostatistics at PRA between 2009 to 2016 prior to joining Covance.
Nigel has been an active member of professional organizations for many years. He has served twice on the PSI Board and on the Scientific Committee. He was the PSI Chair between July 2017 and July 2019, and is currently the Vice-Chair and Secretary. Nigel also served on the EFSPI Council and was the EFSPI President between 2007 and 2010.
Nigel has a Postgraduate Diploma in Mathematical Statistics from Cambridge University (UK) and a BSc (hons) in Mathematics and Statistics from Bradford University (UK).
Outside of work Nigel loves rugby, football, music and visiting the West End.
Upcoming Events
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Joint PSI/EFSPI Pre-Clinical SIG Webinar: Virtual Control Groups in Toxicity Studies
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
Joint PSI/EFSPI Data Science SIG Webinar: Developing Digital Measures (Digital Biomarkers) in Drug Development – insights from Mobilise D consortium
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Webinar: Development of Gene Therapies: Strategic, Scientific, Regulatory and Access Considerations
This webinar will cover the history of cell/gene therapy, major regulatory advances, the role of quantitative scientists in drug development of these novel therapeutics, and discuss opportunities for innovation and product advancement.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
PSI Introduction to Industry Training (ITIT) Course - 2024/2025
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
Statisticians in the Pharmaceutical Industry Executive Office: c/o MCI UK Ltd | Unit 24/22 South | Building 4000 | Langstone Park| Langstone Road | Havant | PO9 1SA | UK